Designing Chimeric Antigen Receptor T cells for treating Diffuse Intrinsic Pontine Glioma

Jenkins, Misty R. (Primary Chief Investigator (PCI))
Purcell, Anthony (Chief Investigator (CI))
Hansford, Jordan R. (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	6/05/19 → 31/12/21

2 Article

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
Pandey, K., Wang, S. S., Mifsud, N. A., Faridi, P., Davenport, A. J., Webb, A. I., Sandow, J. J., Ayala, R., Monje, M., Cross, R. S., Ramarathinam, S. H., Jenkins, M. R. & Purcell, A. W., 11 Aug 2023, In: Frontiers in Oncology. 13, 17 p., 1192448.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma
Wang, S. S., Pandey, K., Watson, K. A., Abbott, R. C., Mifsud, N. A., Gracey, F. M., Ramarathinam, S. H., Cross, R. S., Purcell, A. W. & Jenkins, M. R., 21 Sept 2023, In: Molecular Therapy - Oncolytics. 30, p. 167-180 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

3 Citations (Scopus)

FlowCore
Andrew Fryga (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility
Micromon
Scott Coutts (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility
Monash Proteomics & Metabolomics Facility
Ralf Schittenhelm (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility